The IPO Buzz: Rapport Therapeutics (RAPP) Prices IPO at $17.00 Mid-Point
Rapport Therapeutics (RAPP), a Phase II biotech, priced its IPO at $17.00 – the mid-point of its $16.00-to-$18.00 range – on 8.0 million shares – the number in the prospectus – to raise $136.0 million, the company said on Thursday night, June 6, 2024. Shares of Rapport Therapeutics jumped $1.00 from their IPO price to open at […]
June 6, 2024 Read More